Herrmann John A III
SEC CIK 1610928 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | EVP, CLO | 13.2K | — | $10.24M | 46 | 2021-06-30 | 2023-12-14 |
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
Herrmann John A III made no open-market trades at NVAX in the last 12 months.
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $5.69 | -700 | 13.2K | -5% | -$3,983 |
| D | 2023-12-18 | 2023-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +2,100 | 13.9K | +18% | — |
| D | 2023-06-27 | 2023-06-25 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $6.70 | -278 | 11.8K | -2% | -$1,863 |
| D | 2023-06-27 | 2023-06-25 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +833 | 12.1K | +7% | — |
| D | 2023-03-14 | 2023-03-10 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $6.52 | -1,780 | 11.3K | -14% | -$11.6K |
| D | 2023-03-14 | 2023-03-10 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $6.52 | +4,609 | 13.1K | +55% | +$30.1K |
| D | 2022-12-16 | 2022-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +2,100 | 9,149 | +30% | — |
| D | 2022-12-16 | 2022-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $17.23 | -700 | 8,449 | -8% | -$12.1K |
| D | 2022-09-28 | 2022-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +3,973 | 8,373 | +90% | — |
| DI | 2022-09-28 | 2022-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $18.87 | -258 | 3,384 | -7% | -$4,868 |
| DI | 2022-09-28 | 2022-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +667 | 3,642 | +22% | — |
| D | 2022-09-28 | 2022-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $18.87 | -1,324 | 7,049 | -16% | -$25.0K |
| DI | 2022-08-26 | 2022-08-24 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +2,000 | 3,747 | +114% | — |
| DI | 2022-08-26 | 2022-08-24 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $37.07 | -772 | 2,975 | -21% | -$28.6K |
| D | 2022-06-28 | 2022-06-25 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $51.67 | -278 | 4,400 | -6% | -$14.4K |
| D | 2022-06-28 | 2022-06-25 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +833 | 4,678 | +22% | — |
| DM | 2022-01-05 | 2022-01-03 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $140.91 | -5,000 | 8,045 | -38% | -$704.5K |
| D | 2022-01-05 | 2022-01-03 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 8,845 | +130% | +$95.4K |
| D | 2021-12-22 | 2021-12-20 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 8,845 | +130% | +$95.4K |
| D | 2021-12-22 | 2021-12-20 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $230.00 | -5,000 | 3,845 | -57% | -$1.15M |
| D | 2021-12-16 | 2021-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +2,100 | 4,860 | +76% | — |
| D | 2021-12-16 | 2021-12-14 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $168.43 | -1,015 | 3,845 | -21% | -$171.0K |
| DM | 2021-12-03 | 2021-12-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $196.19 | -5,000 | 6,269 | -44% | -$980.9K |
| D | 2021-12-03 | 2021-12-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 7,760 | +181% | +$95.4K |
| D | 2021-12-01 | 2021-11-29 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 7,760 | +181% | +$95.4K |
| D | 2021-12-01 | 2021-11-29 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $228.72 | -5,000 | 2,760 | -64% | -$1.14M |
| D | 2021-11-05 | 2021-11-03 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 7,760 | +181% | +$95.4K |
| D | 2021-11-05 | 2021-11-03 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $200.00 | -5,000 | 2,760 | -64% | -$1.00M |
| DM | 2021-11-03 | 2021-11-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $163.08 | -5,000 | 5,117 | -49% | -$815.4K |
| D | 2021-11-03 | 2021-11-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 7,760 | +181% | +$95.4K |
| DM | 2021-10-05 | 2021-10-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $174.89 | -5,000 | 3,108 | -62% | -$874.5K |
| D | 2021-10-05 | 2021-10-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 7,760 | +181% | +$95.4K |
| DI | 2021-09-28 | 2021-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +666 | 1,969 | +51% | — |
| D | 2021-09-28 | 2021-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $248.16 | -1,919 | 2,760 | -41% | -$476.2K |
| DI | 2021-09-28 | 2021-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $248.16 | -222 | 1,747 | -11% | -$55.1K |
| D | 2021-09-28 | 2021-09-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +3,973 | 4,679 | +563% | — |
| DI | 2021-09-24 | 2021-08-24 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | F - Tax | $233.01 | -697 | 1,303 | -35% | -$162.4K |
| DI | 2021-09-24 | 2021-08-24 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | — | +2,000 | 2,000 | New | — |
| DM | 2021-09-17 | 2021-09-15 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $229.44 | -5,000 | 706 | -88% | -$1.15M |
| D | 2021-09-17 | 2021-09-15 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 5,706 | +708% | +$95.4K |
| DM | 2021-09-03 | 2021-09-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $247.97 | -5,000 | 5,606 | -47% | -$1.24M |
| D | 2021-09-03 | 2021-09-01 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $19.08 | +5,000 | 5,706 | +708% | +$95.4K |
| DM | 2021-07-28 | 2021-07-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $197.74 | -2,896 | 1,426 | -67% | -$572.6K |
| DM | 2021-07-28 | 2021-07-26 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $14.83 | +2,896 | 1,123 | New | +$43.0K |
| DM | 2021-07-02 | 2021-06-30 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | S - Sale+OE | $212.65 | -2,896 | 1,208 | -71% | -$615.8K |
| DM | 2021-07-02 | 2021-06-30 | NVAX | NOVAVAX INC | Herrmann John A III | EVP, CLO | M - OptEx | $14.83 | +2,896 | 3,602 | +410% | +$42.9K |
Purchase Sale Sale after option exercise All abbreviations